Correlation Between Protagenic Therapeutics and Defence Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Defence Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Defence Therapeutics.

Diversification Opportunities for Protagenic Therapeutics and Defence Therapeutics

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Protagenic and Defence is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Defence Therapeutics

Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 13.0 times more return on investment than Defence Therapeutics. However, Protagenic Therapeutics is 13.0 times more volatile than Defence Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Defence Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  61.00  in Protagenic Therapeutics on September 3, 2024 and sell it today you would lose (2.00) from holding Protagenic Therapeutics or give up 3.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Protagenic Therapeutics  vs.  Defence Therapeutics

 Performance 
       Timeline  
Protagenic Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Defence Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Protagenic Therapeutics and Defence Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protagenic Therapeutics and Defence Therapeutics

The main advantage of trading using opposite Protagenic Therapeutics and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.
The idea behind Protagenic Therapeutics and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope